Des Moines University is the accredited provider and has approved this educational offering. If you have questions regarding continuing education credit, please email cme@dmu.edu.

ACCREDITATION STATEMENTS

• MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University (DMU) and the Iowa Department of Health and Human Services. DMU is accredited by IMS to provide continuing medical education for physicians. DMU designates this live activity for a maximum of 15.75 AMA PRA Category 1 Credit(s)™.  Physicians should only claim credit commensurate with the extent of their participation in the activity. 
• DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 15.75 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
• Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This live activity has been reviewed and approved for 15.75 continuing education contact hour(s). Nurses must attend the entire session to receive credit. Partial session credit is prohibited and will be forfeited.
• Other Health Professionals: This live activity is designated for a maximum of 15.75 AMA PRA Category 1 Credit(s)™.

EDUCATIONAL GRANTS

No ineligible company provided financial support for this continuing education activity. 

Iowa’s Annual Governors Conference on Substance Use is sponsored by the Iowa Department of Health and Human Services (Iowa HHS) and coordinated by Iowa State University- Conference Planning and Management. Funding is provided by state appropriations, the State Opioid Response (CFDA 93.788) federal grant, and the Substance Abuse Prevention and Treatment Block Grant (CFDA 93.959).

DISCLOSURE

The speaker(s) will disclose if any pharmaceuticals, medical procedures, and devices discussed are investigational or unapproved by the U.S. Food and Drug Administration (FDA). The determination of educational content and the selection of speakers is the responsibility of the activity director. 

Relevant to the content of this educational activity, the following individuals have no conflict(s) with ineligible companies to disclose.

• Amanda Eleazer, PRC – Speaker
• Amelia Roeschlein, DSW, MA, LMFT – Facilitator
• Amy Croll, LMSW, CPS – Speaker
• Chris Ries, MPH – Planning Committee Member
• Christopher Jones, PharmD, DrPH, MPH – Speaker
• DeAnn Decker – Speaker
• Emily Bhargava – Speaker
• Gloria Uridel – Speaker
• Heather Chapman, PhD, ICGCII, BACC – Speaker
• Jennifer Boehm – Activity Coordinator
• Jennifer Robertson-Hill, LMHC – Activity Director
• Jodee Goche, MPS, CPS – Speaker
• Jonathan Neufeld, PhD – Speaker
• Josh Luftig, PA-C – Speaker
• Joshua Rubin, MPP – Speaker
• Judge Jeffrey Smith – Speaker
• Kelly Garcia – Speaker
• Kim Freese, LAC – Speaker
• Laura Clery – Speaker
• Laura Larkin, MS, LMSW – Speaker
• Lauren Sisler – Speaker
• Lori Frick, MA, LMHC – Speaker
• Marissa Eyanson – Speaker
• Meghan Mead, JD – Speaker
• Mirna Herrera, MA MT-BC, CPS – Speaker
• Monty Burks, PhD, CPRS – Speaker
• Nicholas Bormann, MD – Speaker
• Nichole Nidey, PhD – Speaker
• Paolo del Vecchio, MSW – Speaker
• Rebecca Bishop, MA – Speaker
• Rebecca Rong – Planning Committee Member
• Sandra Del Sesto, MEd, ACPS – Facilitator
• Scott Boyles, LAC – Speaker
• Shelley Horak, EdD, MPH, CHES – Speaker
• Stephanie Strutner, MPH, CPSII – Speaker
• Susan Walker – Speaker
• Thomas Eachus, LISW – Speaker
• Tom Coderre – Speaker

Relevant to the content of this educational activity, the following individual(s) have conflict(s) with ineligible companies to disclose. All relevant financial relationships have been mitigated.

• Linda Kalin, BS, RN, CSPI – Speaker
  Ms. Kalin does not have a financial relationship with an ineligible company; however, she does intend to discuss the off-label use of a commercial product or device. She agrees to inform learners of such.
• Lorene Mein, DNP, ARNP, FNP-BC – Speaker
  Dr. Mein does not have a financial relationship with an ineligible company; however, she does intend to discuss the off-label use of a commercial product or device. She agrees to inform learners of such.

DISCLAIMER

The information provided in this activity is for continuing education purposes only. It is not a substitute for a healthcare provider’s independent medical judgment regarding diagnostic and treatment options for a specific patient’s medical condition. The content of this educational offering does not reflect the views of Des Moines University.